Evidence map›Paper›PMID 27733922›Full record

ArticleHealthcare technology letters2016

Predicting adherence of patients with HF through machine learning techniques.

Georgia Spiridon Karanasiou, Evanthia Eleftherios Tripoliti, Theofilos Grigorios Papadopoulos, Fanis Georgios Kalatzis, Yorgos Goletsis, Katerina Kyriakos Naka, Aris Bechlioulis, Abdelhamid Errachid, Dimitrios Ioannis Fotiadis

Registry-linked trialAbstract read
In one paragraph

Article in Healthcare technology letters, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06161181 (Enhancing Therapy Adherence Among Metastatic Breast Cancer Patients), which is not on this map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06161181 nacompletednot on this mapstarted 2023, after this paper: background citation

Enhancing Therapy Adherence Among Metastatic Breast Cancer Patients: the Study Protocol

TypeinterventionalSponsorEuropean Institute of OncologyRan2023 to 2024Enrolled94ConditionsMetastatic Breast CancerArmsDecision Support System
3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Georgia Spiridon KaranasiouDepartment of Biomedical Research , Institute of Molecular Biology and Biotechnology , FORTH, GR 45110 Ioannina , Greece.
Evanthia Eleftherios TripolitiDepartment of Biomedical Research , Institute of Molecular Biology and Biotechnology , FORTH, GR 45110 Ioannina , Greece.
Theofilos Grigorios PapadopoulosUnit of Medical Technology and Intelligent Information Systems , University of Ioannina , GR 45110 Ioannina , Greece.
Fanis Georgios KalatzisDepartment of Biomedical Research , Institute of Molecular Biology and Biotechnology , FORTH, GR 45110 Ioannina , Greece.
Yorgos GoletsisDepartment of Economics , University of Ioannina , GR 45110 Ioannina , Greece.
Katerina Kyriakos NakaMichaelidion Cardiac Center, University of Ioannina, GR 45110 Ioannina, Greece; Department of Cardiology, University of Ioannina, GR 45110 Ioannina, Greece.
Aris BechlioulisMichaelidion Cardiac Center, University of Ioannina, GR 45110 Ioannina, Greece; Department of Cardiology, University of Ioannina, GR 45110 Ioannina, Greece.
Abdelhamid ErrachidUniversité de Lyon, Institut de Sciences Analytiques, ISA , FR 69100 Villeurbanne , France.
Dimitrios Ioannis FotiadisDepartment of Biomedical Research, Institute of Molecular Biology and Biotechnology, FORTH, GR 45110 Ioannina, Greece; Unit of Medical Technology and Intelligent Information Systems, University of Ioannina, GR 45110 Ioannina, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart failure (HF) is a chronic disease characterised by poor quality of life, recurrent hospitalisation and high mortality. Adherence of patient to treatment suggested by the experts has been proven a significant deterrent of the above-mentioned serious consequences. However, the non-adherence rates are significantly high; a fact that highlights the importance of predicting the adherence of the patient and enabling experts to adjust accordingly patient monitoring and management. The aim of this work is to predict the adherence of patients with HF, through the application of machine learning techniques. Specifically, it aims to classify a patient not only as medication adherent or not, but also as adherent or not in terms of medication, nutrition and physical activity (global adherent). Two classification problems are addressed: (i) if the patient is global adherent or not and (ii) if the patient is medication adherent or not. About 11 classification algorithms are employed and combined with feature selection and resampling techniques. The classifiers are evaluated on a dataset of 90 patients. The patients are characterised as medication and global adherent, based on clinician estimation. The highest detection accuracy is 82 and 91% for the first and the second classification problem, respectively.

Indexed as

cardiologychronic diseasediseasesheart failurelearning (artificial intelligence)machine learning techniquesmedicationnutritionpatient adherence predictionpatient monitoringpatient treatmentphysical activity

Identifiers

PMID27733922
PMCPMC5048333

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.